AdaptHealth (AHCO) Depreciation & Amortization (CF) (2019 - 2025)
AdaptHealth has reported Depreciation & Amortization (CF) over the past 7 years, most recently at $97.5 million for Q4 2025.
- Quarterly results put Depreciation & Amortization (CF) at $97.5 million for Q4 2025, up 7.7% from a year ago — trailing twelve months through Dec 2025 was $381.9 million (up 4.54% YoY), and the annual figure for FY2025 was $381.9 million, up 4.54%.
- Depreciation & Amortization (CF) for Q4 2025 was $97.5 million at AdaptHealth, roughly flat from $97.7 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for AHCO hit a ceiling of $102.3 million in Q4 2022 and a floor of $47.2 million in Q1 2021.
- Median Depreciation & Amortization (CF) over the past 5 years was $92.3 million (2022), compared with a mean of $87.0 million.
- Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 264.03% in 2021 and later dropped 9.75% in 2023.
- AdaptHealth's Depreciation & Amortization (CF) stood at $77.2 million in 2021, then surged by 32.52% to $102.3 million in 2022, then fell by 9.75% to $92.4 million in 2023, then decreased by 1.98% to $90.5 million in 2024, then grew by 7.7% to $97.5 million in 2025.
- The last three reported values for Depreciation & Amortization (CF) were $97.5 million (Q4 2025), $97.7 million (Q3 2025), and $92.4 million (Q2 2025) per Business Quant data.